A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility

Cited by papers we hold 8

• Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets · 2024
  No notice
• Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases · 2024
  No notice
• Gut microbiota derived bile acid metabolites maintain the homeostasis of gut and systemic immunity · 2023
  No notice
• Dysbiotic Gut Bacteria in Obesity: An Overview of the Metabolic Mechanisms and Therapeutic Perspectives of Next-Generation Probiotics · 2022
  No notice
• The gut microbiota-bile acid axis links the positive association between chronic insomnia and cardiometabolic diseases · 2022
  No notice
• Gut microbiota-bile acid crosstalk contributes to the rebound weight gain after calorie restriction in mice · 2022
  No notice
• Hyocholic acid species as novel biomarkers for metabolic disorders · 2021
  No notice
• Targeting the alternative bile acid synthetic pathway for metabolic diseases · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.